npj Precision Oncology (Sep 2024)

Immune-related cell death index and its application for hepatocellular carcinoma

  • Zhao Sun,
  • Hao Liu,
  • Qian Zhao,
  • Jie-Han Li,
  • San-Fei Peng,
  • Zhen Zhang,
  • Jing-Hua Yang,
  • Yang Fu

DOI
https://doi.org/10.1038/s41698-024-00693-9
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 17

Abstract

Read online

Abstract Regulated cell death (RCD) plays a crucial role in the immune microenvironment, development, and progression of hepatocellular carcinoma (HCC). However, reliable immune-related cell death signatures have not been explored. In this study, we collected 12 RCD modes (e.g., apoptosis, ferroptosis, and cuproptosis), including 1078 regulators, to identify immune-related cell death genes based on HCC immune subgroups. Using a developed competitive machine learning framework, nine genes were screened to construct the immune-related cell death index (IRCDI), which is available for online application. Multi-omics data, along with clinical features, were analyzed to explore the HCC malignant heterogeneity. To validate the efficacy of this model, more than 18 independent cohorts, including survival and diverse treatment cohorts and datasets, were utilized. These findings were further validated using in-house samples and molecular biological experiments. Overall, the IRCDI may have a wide application in individual therapeutic decision-making and improving outcomes for HCC patients.